Viewing Study NCT00005858


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-01-24 @ 7:11 AM
Study NCT ID: NCT00005858
Status: COMPLETED
Last Update Posted: 2019-11-04
First Post: 2000-06-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
Sponsor: University of Maryland, Baltimore
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
None Breast Cancer View
None Colorectal Cancer View
None Lung Cancer View
None Ovarian Cancer View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III colon cancer View
None stage IV colon cancer View
None stage IV breast cancer View
None stage IIIA breast cancer View
None recurrent breast cancer View
None stage IIIB breast cancer View
None recurrent non-small cell lung cancer View
None stage II pancreatic cancer View
None stage III pancreatic cancer View
None recurrent pancreatic cancer View
None recurrent colon cancer View
None stage III ovarian epithelial cancer View
None stage IV ovarian epithelial cancer View
None recurrent ovarian epithelial cancer View
None stage III bladder cancer View
None recurrent bladder cancer View
None stage IV bladder cancer View
None stage IIIA non-small cell lung cancer View
None stage IIIB non-small cell lung cancer View
None stage IV non-small cell lung cancer View
None ovarian stromal cancer View
None stage III ovarian germ cell tumor View
None stage IV ovarian germ cell tumor View
None recurrent ovarian germ cell tumor View
None borderline ovarian surface epithelial-stromal tumor View
None ovarian sarcoma View
None male breast cancer View
None stage IV pancreatic cancer View